http://www.pharmalot.com/2008/04/will-insurers-reduce-coverage-for-vytorin/ News, Comment and Conversation Fri, 10 Feb 2012 21:18:10 +0000 http://wordpress.org/?v=2.6.2 http://www.pharmalot.com/2008/04/will-insurers-reduce-coverage-for-vytorin/#comment-252719 Greg Evans Fri, 04 Apr 2008 16:53:01 +0000 http://www.pharmalot.com/2008/04/will-insurers-reduce-coverage-for-vytorin/#comment-252719 I believe insurers and pharmacy benefit management companies will continue coverage of Vytorin. Most likely, it will lose preferred status, (formulary Tier 2), and move to non-preferred brand, (formulary Tier 3 or Tier 4), depending on the drug reimbursement system in the health plan. As an example, most preferred products are available at a $20.00 co-pay. Moving to Tier 3 or Tier 4, will require a $50.00 - $75.00 co-pay, or in some plans 80% of the retail selling price. The goal here is to get the patient to request a drug switch to a lesser costing drug. There will still be a major number of patients that will want to stay with Vytorin. New prescriptions will be much more affected than refill prescriptions. I believe insurers and pharmacy benefit management companies will continue coverage of Vytorin. Most likely, it will lose preferred status, (formulary Tier 2), and move to non-preferred brand, (formulary Tier 3 or Tier 4), depending on the drug reimbursement system in the health plan. As an example, most preferred products are available at a $20.00 co-pay. Moving to Tier 3 or Tier 4, will require a $50.00 - $75.00 co-pay, or in some plans 80% of the retail selling price. The goal here is to get the patient to request a drug switch to a lesser costing drug. There will still be a major number of patients that will want to stay with Vytorin. New prescriptions will be much more affected than refill prescriptions.

]]> http://www.pharmalot.com/2008/04/will-insurers-reduce-coverage-for-vytorin/#comment-244202 The Healthcare Channel Wed, 02 Apr 2008 17:35:20 +0000 http://www.pharmalot.com/2008/04/will-insurers-reduce-coverage-for-vytorin/#comment-244202 This is consistent with what we reported back on January 31 would likely happen http://blogs.wsj.com/health/2008/01/31/vytorin-may-lose-preferred-status-in-medicare-plans/?mod=WSJBlog This is consistent with what we reported back on January 31 would likely happen
http://blogs.wsj.com/health/2008/01/31/vytorin-may-lose-preferred-status-in-medicare-plans/?mod=WSJBlog

]]>